Cytovance Biologics' Private Equity Round

Cytovance Biologics raised a round of funding on March 15, 2011. Investors include Great Point Partners.

Cytovance Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentat…

Articles about Cytovance Biologics' Private Equity Round: